Lung cancer Cancer Malignant neoplasm of bronchus and lung
Conditions
Interventions
PEOPLE-Hull is a programme of research incorporating two interlinked phases. The first involves community groups and the general public and has been the subject of University ethics application and ap
Sponsors
University of Hull
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Community events: All members of the public over 18 years old who are interested in participating in the study and able to give informed consent Practice activities: All patients who have agreed to participate in the study and have consulted for respiratory symptoms during the study period at the recruited practices All healthcare professionals and practice staff at the recruited practices
Exclusion criteria
Exclusion criteria: Community events: 1. All members of the public over 18 years old who are not interested in participating in the study 2. Members of the public less than 18 years old 3. Those unable to give informed consent Practice activities: Patients consulting for non-respiratory symptoms at the recruited practices Healthcare professionals and practice staff at practices not participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The number of early-stage lung cancers diagnosed and lung resections, measured using hospital Trust records (MDT records and LUCADA audit data) at the following timepoints: community intervention: 2 years pre-intervention March 2020 (March 2018) and 18 months post-intervention (September 2021); practice intervention (March/April 2021-December 2021-February/March 2022): pre-intervention (March/April 2019) and post-intervention (September 2023) 2. The number of advanced-stage lung cancers diagnosed, measured using MDT records and LUCADA audit data at the following timepoints: community intervention: 2 years pre-intervention March 2020 (March 2018) and 18 months post-intervention (September 2021); practice intervention (March/April 2021-December 2021-February/March 2022): pre-intervention (March/April 2019) and post-intervention (September 2023) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The number of monthly consultations of smokers or ex-smokers during the study period measured using GP records at 2 years pre-practice intervention (March 2019) and 18 months post-practice intervention (September 2023) 2. The number of monthly consultations for respiratory symptoms by smokers or ex-smokers during the study period measured using GP records at 2 years pre-practice intervention (March 2019) and 18 months post-practice intervention (September 2023) 3. The number of monthly consultations for lung symptoms by lung cancer patients measured using GP records at 1 year or 3 months pre-referral or emergency presentation and 18 months post-referral pr emergency presentation 4. The number of chest x-rays conducted, measured using GP records at 2 years pre-practice intervention, during the practice intervention and 18 months post-practice intervention 5. The number of GP referrals (both urgent and non-urgent) measured using GP records at 2 years pre-practice intervention and 18 months post-practice intervention | — |
Countries
England, United Kingdom
Outcome results
None listed